Ntagi
Ntagi News
NTAGI to discuss whether to allow early administration of precaution COVID dose to those travelling abroad
The National Technical Advisory Group on Immunisation (NTAGI) may also review the data on COVID-19 vaccines for the 5-12 age group
Health
First dose of Sputnik V to be given as booster to those vaccinated with Russian vaccine, NTAGI recommends
The two doses of Sputnik V vaccine have separate compositions -- the first dose contains a recombinant adenovirus type 26 (rAd26-S) and the second dose a recombinant adenovirus 5 (rAd5-S)
Why India's vaccine advisory body recommends reducing second-dose gap for Covishield
The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to eight to 16 weeks, from the current gap of 12 to 16
Union Budget 2022: Why Centre has reduced COVID-19 vaccine budget to Rs 5,000 crore
Experts are of the opinion that the reduction in allocation of funds hints that the Centre has done its job of providing free vaccines across the country and people may have to shell out for booster shots
Health
Gap in our understanding of the science behind COVID-19 booster dose, says vaccine panel chief
We must understand that our understanding of Omicron is still evolving and it will take another two to three weeks to derive any concrete understanding, Dr NK Arora said
No need for boosters, two jabs of vaccine enough to fight COVID, says NTAGI member
Dr Jayaprakash Muliyil said NTAGI members have been deliberating over the issue of launching booster doses in India and another meeting is slated to happen next week
Looking into whether COVID-19 booster doses needed, Centre tells Delhi HC
Centre told the court that the current knowledge about the duration of immunity offered by COVID-19 vaccines in India is limited and will clearly be known only over a period of time
NTAGI to consider administering 'additional' dose of COVID-19 vaccine to immunocompromised
A booster dose is given to an individual after a predefined period when the immune response due to primary vaccination is presumed to have declined
Has India reached the stage of assured and sustainable COVID-19 vaccine supply?
When it comes to vaccine supply, India is currently in a comfortable position. However, the coronavirus pandemic is not over yet
No scientific evidence to support need for booster vaccine dose against COVID-19, says ICMR chief
According to sources, the booster dose issue is likely to be discussed in the next meeting of the National Technical Advisory Group on Immunisation in India
Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October
The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi
Reducing gap between two doses of Covishield being considered, say sources; Centre denies reports
In May, the Centre further extended the gap between two doses of Covishield from 6-8 weeks to 12-16 weeks and said it was based on scientific evidence
Centre increases gap between Covishield doses to 12-16 weeks: All you need to know
This is the third time in three months that the Central Government has widened the intervals between Covishield doses
Increase gap between Covishield vaccine doses to 4-8 weeks, Centre tells states
This decision to revise the interval between doses from 4-6 weeks is applicable only to Covishield and not to Covaxin, the Union health ministry said